Trials / Unknown
UnknownNCT04526301
Home With TablO outcoMEs (HOME) Registry
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Outset Medical · Industry
- Sex
- All
- Age
- 15 Years
- Healthy volunteers
- Not accepted
Summary
Prospective, multicenter, single arm, post-market study to evaluate real world clinical outcomes in ESRD patients receiving in-home dialysis on the Tablo Hemodialysis System.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Tablo Hemodialysis System | Home hemodialysis treatments \~4 times a week. |
Timeline
- Start date
- 2020-07-14
- Primary completion
- 2024-07-31
- Completion
- 2024-07-31
- First posted
- 2020-08-25
- Last updated
- 2022-09-23
Locations
10 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04526301. Inclusion in this directory is not an endorsement.